All In Biotech

Drug Trial Radar · NCT01695187

NB-001 Treatment of Recurrent Herpes Labialis

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 Treatment of Recurrent Herpes Labialis

Last checked: Nov 19, 2026Latest source record: Jun 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 362 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

362

Actual

Start

Oct 2012

Primary completion

Jun 2013

Study completion Jul 2013

Sponsor

Lead sponsor
NanoBio CorporationIndustry
Sponsor type
Industry
First posted
Sep 27, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to test the hypothesis that time to healing of a cold sore will be lower in the active treatment arm of the study when compared to the vehicle (placebo). Subjects with a history of cold sores will be enrolled and administered active treatment or placebo in a blinded manner. Subjects will then be followed to assess time to healing.

Conditions

  • Herpes Labialis

Interventions

  • NB-001 (0.3%)Drug

    Topical administration at least five times throughout the day

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to healing of the primary lesion complex (in days or fraction thereof) as assessed by the investigator.Time frame: Time to healing will be assessed from treatment onset to resolution of symptoms (maximum of 16 days)

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Radiant Research, Inc

    Chandler, Arizona

  • Radiant Research, Inc

    Tucson, Arizona

  • Radiant Research, Inc. Chicago

    Chicago, Illinois

  • Central Kentucky Research Associates, Inc.

    Lexington, Kentucky

  • Radiant Research, Inc.

    Edina, Minnesota

  • The Center for Pharmaceutical Research, P.C.

    Kansas City, Missouri

  • Radiant Research, Inc.

    St Louis, Missouri

  • Radiant Research, Inc.

    Anderson, South Carolina

  • Coastal Carolina Research Center

    Mt. Pleasant, South Carolina

  • Research Across America

    Dallas, Texas

  • Radiant Research, Inc.

    San Antonio, Texas

  • New River Valley Research Institute

    Christiansburg, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.